BioWorld - Tuesday, March 31, 2026

BioWorld Science

Dec. 31, 2018

View Archived Issues

Taisho presents safety and PK data for TS-134

Read More

Astatine-211 targeted to CD38 tested in minimal residual disease multiple myeloma models

Read More

First-in-human data for JNJ-54175446 published

Read More

Phase II results for the dissociative steroidal anti-inflammatory drug vamorolone in DMD

Read More

G0S2 is epigenetically silenced in IDH1-mutant glioma, leading to improved prognosis

Read More

Amgen develops anti-GIPR antibody

Read More

Immune cells can cause pain for brain

Read More

Inducing senescence sets off antitumor response

Read More

Innate immunity shuttles antigens to B-cell centers

Read More

Novel pyrrolopyridine analogues show human CMV-inhibitory activity by unusual mechanism of action

Read More

Novel SIRT6 allosteric activator, MDL-800, suppresses tumor growth in xenograft models of HCC

Read More

Transcription factor suppresses immunity, halts lupus in mice

Read More

Emergent BioSolutions makes FDA submission for potential emergency use of NuThrax

Read More

InventisBio and Betta Pharma sign Chinese agreement for D-0316

Read More

University of Southern California patent describes agents for imaging ADP-ribosylation

Read More

Anti-RSV compounds reported in Enanta Pharmaceuticals patent

Read More

Bristol-Myers Squibb describes formyl peptide receptor agonists

Read More

PTC Therapeutics patents compounds for Huntington's disease

Read More

Tianjin Zhongxin Pharmaceutical Research Center reports agents for treatment of cancer

Read More

National Health Research Institutes reports development of tyrosine kinase inhibitors

Read More